{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T12:49:36Z","timestamp":1692967776501},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T00:00:00Z","timestamp":1568678400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T00:00:00Z","timestamp":1568678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Schmerz"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00482-019-00397-1","type":"journal-article","created":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T15:03:05Z","timestamp":1568732585000},"page":"437-442","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cannabispr\u00e4parate f\u00fcr die Therapie chronischer Schmerzen"],"prefix":"10.1007","volume":"33","author":[{"given":"Marc","family":"Heidbreder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"van Treeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,17]]},"reference":[{"key":"397_CR1","volume-title":"Supplementary information on cannabis-based products for medicinal use","author":"National Health Service","year":"2018","unstructured":"National Health Service (2018) Supplementary information on cannabis-based products for medicinal use. \n                    https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2018\/11\/letter-additional-guidance-on-cannabis-based-products-for-medicinal-use.pdf\n                    \n                  . Zugegriffen: 17. Juli 2019"},{"key":"397_CR2","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/ejp.1147","volume":"22","author":"N Krcevski-Skvarc","year":"2018","unstructured":"Krcevski-Skvarc\u00a0N, Wells\u00a0C, H\u00e4user\u00a0W (2018) Availability and approval of cannabis-based medicines for chronic pain management and palliative\/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation. Eur J Pain 22:440\u2013454","journal-title":"Eur J Pain"},{"key":"397_CR3","volume-title":"Sozialmedizinische Begutachtung von Cannabinoiden nach \u00a7 31 Absatz 6 SGB V (Richtlinie des GKV-Spitzenverbandes nach \u00a7 282 SGB V)","author":"MDS","year":"2018","unstructured":"MDS (2018) Sozialmedizinische Begutachtung von Cannabinoiden nach \u00a7 31 Absatz 6 SGB V (Richtlinie des GKV-Spitzenverbandes nach \u00a7 282 SGB V). \n                    https:\/\/www.mds-ev.de\/uploads\/media\/downloads\/BGA_Cannabis_2017_08_29.pdf\n                    \n                  . Zugegriffen: 17. Juli 2019"},{"key":"397_CR4","volume-title":"Chroniker-Richtlinie des Gemeinsamen Bundesausschusses zur Umsetzung der Regelungen in \u00a7 62 f\u00fcr schwerwiegend chronisch Erkrankte (\u201eChroniker-Richtlinie\u201c)","author":"Gemeinsamer Bundesausschuss","year":"2017","unstructured":"Gemeinsamer Bundesausschuss (2017) Chroniker-Richtlinie des Gemeinsamen Bundesausschusses zur Umsetzung der Regelungen in \u00a7 62 f\u00fcr schwerwiegend chronisch Erkrankte (\u201eChroniker-Richtlinie\u201c). \n                    https:\/\/www.g-ba.de\/downloads\/62-492-1530\/RL-Chroniker_2017-11-17.pdf\n                    \n                  . Zugegriffen: 17. Juli 2019"},{"key":"397_CR5","volume-title":"Richtlinie des Gemeinsamen Bundesausschusses \u00fcber die Verordnung von Arzneimitteln in der vertrags\u00e4rztlichen Versorgung (Arzneimittel-Richtlinie\/AM-RL)","author":"Gemeinsamer Bundesausschuss","year":"2019","unstructured":"Gemeinsamer Bundesausschuss (2019) Richtlinie des Gemeinsamen Bundesausschusses \u00fcber die Verordnung von Arzneimitteln in der vertrags\u00e4rztlichen Versorgung (Arzneimittel-Richtlinie\/AM-RL). \n                    https:\/\/www.g-ba.de\/downloads\/62-492-1878\/AM-RL_2019-05-16_iK_2019-07-05_AT-04-07-2019-B2.pdf\n                    \n                  . Zugegriffen: 17. Juli 2019"},{"key":"397_CR6","volume-title":"Urteil vom 26.09.2006 \u2013 B 1 KR 14\/06\u202fR","author":"Bundessozialgericht","year":"2006","unstructured":"Bundessozialgericht (2006) Urteil vom 26.09.2006 \u2013 B 1 KR 14\/06\u202fR. \n                    https:\/\/sozialgerichtsbarkeit.de\/sgb\/esgb\/show.php?modul=esgb&id=61101\n                    \n                  . Zugegriffen: 17. Juli 2019"},{"key":"397_CR7","volume-title":"Urteil vom 14.05.2014 \u2013 B 6 KA 21\/13\u202fR","author":"Bundessozialgericht","year":"2014","unstructured":"Bundessozialgericht (2014) Urteil vom 14.05.2014 \u2013 B 6 KA 21\/13\u202fR. \n                    https:\/\/sozialgerichtsbarkeit.de\/sgb\/esgb\/show.php?modul=esgb&id=172549\n                    \n                  . Zugegriffen: 17. Juli 2019"},{"key":"397_CR8","volume-title":"Urteil vom 30.01.2019 \u2013 L 11 KR 442\/18 B ER","author":"Landessozialgericht Nordrhein-Westfalen","year":"2019","unstructured":"Landessozialgericht Nordrhein-Westfalen (2019) Urteil vom 30.01.2019 \u2013 L 11 KR 442\/18 B ER. \n                    https:\/\/sozialgerichtsbarkeit.de\/sgb\/esgb\/show.php?modul=esgb&id=205083\n                    \n                  . Zugegriffen: 17. Juli 2019"},{"key":"397_CR9","volume-title":"Medizinalcannabis und cannabisbasierte Arzneimittel: Ein Appell an \u00c4rzte, Journalisten, Krankenkassen und Politiker f\u00fcr einen verantwortungsvollen Umgang","author":"Deutsche Gesellschaft f\u00fcr Palliativmedizin","year":"2019","unstructured":"Deutsche Gesellschaft f\u00fcr Palliativmedizin (2019) Medizinalcannabis und cannabisbasierte Arzneimittel: Ein Appell an \u00c4rzte, Journalisten, Krankenkassen und Politiker f\u00fcr einen verantwortungsvollen Umgang. \n                    https:\/\/www.dgpalliativmedizin.de\/phocadownload\/stellungnahmen\/20190417_Appell_Medizinalhanf_und_Cannabisbasierte_Arzneimittel.pdf\n                    \n                  . Zugegriffen: 17. Juli 2019"},{"key":"397_CR10","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s00103-019-02968-0","volume":"62","author":"G Schmidt-Wolf","year":"2019","unstructured":"Schmidt-Wolf\u00a0G, Cremer-Schaeffer\u00a0P (2019) Begleiterhebung zur Anwendung von Cannabisarzneimitteln in Deutschland \u2013 Zwischenauswertung. Bundesgesundheitsblatt 62:845\u2013854","journal-title":"Bundesgesundheitsblatt"},{"key":"397_CR11","volume-title":"Stellungnahme der Bundes\u00e4rztekammer und der Arzneimittelkommission der deutschen \u00c4rzteschaft vom 14. September 2016","author":"Bundes\u00e4rztekammer","year":"2016","unstructured":"Bundes\u00e4rztekammer (2016) Stellungnahme der Bundes\u00e4rztekammer und der Arzneimittelkommission der deutschen \u00c4rzteschaft vom 14. September 2016. \n                    https:\/\/www.bundestag.de\/resource\/blob\/459680\/c35b605822777039da190d980ea4244d\/18_14_194_2_baek-data.pdf\n                    \n                  . Zugegriffen: 17. Juli 2019"},{"key":"397_CR12","first-page":"17","volume-title":"Cannabis: Potenzial und Risiko: Eine wissenschaftliche Bestandsaufnahme","author":"M Schneider","year":"2019","unstructured":"Schneider\u00a0M, Lutz\u00a0B (2019) Cannabinoide. In: Hoch\u00a0E, Friemel\u00a0C, Schneider\u00a0M (Hrsg) Cannabis: Potenzial und Risiko: Eine wissenschaftliche Bestandsaufnahme, 1.\u00a0Aufl. Springer, Berlin, Heidelberg, S\u00a017\u201320","edition":"1"},{"key":"397_CR13","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.drugpo.2019.03.006","volume":"68","author":"J Manthey","year":"2019","unstructured":"Manthey\u00a0J (2019) Cannabis use in europe: Current trends and public health concerns. Int J Drug Policy 68:93\u201396","journal-title":"Int J Drug Policy"},{"key":"397_CR14","volume-title":"FAQ Cannabidiol","author":"Bundesamt f\u00fcr Verbraucherschutz und Lebensmittelsicherheit","year":"2019","unstructured":"Bundesamt f\u00fcr Verbraucherschutz und Lebensmittelsicherheit (2019) FAQ Cannabidiol. \n                    https:\/\/www.bvl.bund.de\/DE\/01_Lebensmittel\/04_AntragstellerUnternehmen\/13_FAQs\/FAQ_Cannabidiol\/FAQ_Cannabidiol_node.html\n                    \n                  . Zugegriffen: 17. Juli 2019"},{"key":"397_CR15","volume-title":"Verordnung \u00fcber die Verschreibungspflicht von Arzneimitteln (Arzneimittelverschreibungsverordnung \u2013 AMVV)","author":"Bundesamt f\u00fcr Justiz","year":"2019","unstructured":"Bundesamt f\u00fcr Justiz (2019) Verordnung \u00fcber die Verschreibungspflicht von Arzneimitteln (Arzneimittelverschreibungsverordnung \u2013 AMVV). \n                    https:\/\/www.gesetze-im-internet.de\/amvv\/anlage_1.html\n                    \n                  . Zugegriffen: 17. Juli 2019"},{"key":"397_CR16","volume-title":"Prescribing Information EPIDIOLEX","author":"US Food","year":"2018","unstructured":"Food\u00a0US, Administration\u00a0D (2018) Prescribing Information EPIDIOLEX. \n                    https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/210365lbl.pdf\n                    \n                  . Zugegriffen: 17. Juli 2019"},{"key":"397_CR17","unstructured":"European Medicines Agency. \n                    https:\/\/www.ema.europa.eu\/en\/documents\/smop-initial\/chmp-summary-positive-opinion-epidyolex_en.pdf\n                    \n                  . Zugegriffen: 25. Juli 2019"},{"key":"397_CR18","volume-title":"H\u00e4rtefallprogramme\/Compassionate Use","author":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte","year":"2019","unstructured":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte (2019) H\u00e4rtefallprogramme\/Compassionate Use. \n                    https:\/\/www.bfarm.de\/DE\/Arzneimittel\/Arzneimittelzulassung\/KlinischePruefung\/CompassionateUse\/Tabelle\/_node.html;jsessionid=9F15B7E2F22B1718F59D691F2F369815.1_cid344\n                    \n                  . Zugegriffen: 17. Juli 2019"}],"container-title":["Der Schmerz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-019-00397-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00482-019-00397-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-019-00397-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T23:32:36Z","timestamp":1600212756000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00482-019-00397-1"}},"subtitle":["Problemfelder bei medizinischen Begutachtungen aus der Erfahrung des MDK Nord"],"short-title":[],"issued":{"date-parts":[[2019,9,17]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["397"],"URL":"https:\/\/doi.org\/10.1007\/s00482-019-00397-1","relation":{},"ISSN":["0932-433X","1432-2129"],"issn-type":[{"value":"0932-433X","type":"print"},{"value":"1432-2129","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,17]]},"assertion":[{"value":"17 September 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0Heidbreder und B.\u00a0van Treeck geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}